Ludwig Enterprises, Inc. (OTCPK: LUDG)
Health Care · Biotechnology · US
$0.00
-65.00% today · -94.9% 1Y
Ludwig Enterprises, Inc. (OTCPK: LUDG) operates in the Biotechnology industry within the Health Care sector. The company is valued at $585.08K and employs 5 people.
Over the last twelve months the share price has lost 94.9%, trading between 0.00 and 0.08.
Tweenvest scores Ludwig Enterprises, Inc. across four factors: quality 23/100, value 39/100. Its strongest factor is value.
LUDG price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $585.08K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- 1.51
- 52-week high
- $0.08
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 167.17M
- Employees
- 5
- Next earnings
- —
About Ludwig Enterprises, Inc.
Operating within the United States, Ludwig Enterprises, Inc. is a broadcasting firm. The company's primary offering is 'The One,' a versatile, mobile, and multi-channel digital two-way communication device. This device provides listeners with access to 50 distinct digital programming channels, including content in various languages such as Filipino, Pakistani, Hebrew, Chinese, Greek, and Russian. Additionally, 'The One' broadcasts a wide range of English programming, from classic radio shows, news, and audiobooks to educational, religious, and diverse music genres like techno and classical. Ludwig Enterprises, Inc. was founded in 1988 and is headquartered in Pompano Beach, Florida.
- ISIN
- US54973P4019
- Founded
- 1988
- Listed since
- Aug 3, 2012
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| SQZ Biotechnologies CompanyOTCPK: SQZB | $707.79K | $0.02 | -0.41% |
| ZyVersa Therapeutics, Inc.OTCPK: ZVSA | $647.67K | $0.08 | -19.19% |
| Biodexa Pharmaceuticals PlcNasdaqCM: BDRX | $637.92K | $0.62 | -8.30% |
| Entheon Biomedical Corp.CNSX: ENBI.X | $586.97K | CA$0.06 | +20.00% |
| IntegraGen SAENXTPA: ALINT | $519.56K | €0.04 | -40.00% |
| NovelStem International Corp.OTCPK: NSTM | $468.66K | $0.01 | -7.41% |
| Sorrento Therapeutics, Inc.OTCPK: SRNE | $434.97K | $0.00 | +166.67% |
| Vaxil Bio Ltd.TSXV: VXL | $405.24K | CA$0.15 | -3.33% |
Figures last refreshed Oct 4, 2026.